Bio-Rad Laboratories BIO
NYSE BIO
$360.50 +6.00 (+1.69%)
As of: Oct 21, 2026 · 3:59 PM EDT

Bio-Rad Laboratories (BIO) Curent Deferred Tax Liability (2013 - 2014)

Updated

Analysis

Bio-Rad Laboratories (BIO) Curent Deferred Tax Liability (2013 - 2014) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Curent Deferred Tax (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn -
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn -
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn -
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn -
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn -
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn -
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn -
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn -
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn -
10 Bio-Rad Laboratories 9.69 Bn 3.54 Bn 345.80 Mn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2014 13.76 Mn
Dec 31, 2013 9.45 Mn
API Access

Bio-Rad Laboratories Curent Deferred Tax Liability API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=curent-deferred-tax-liability&ticker=BIO&period=max&api_key=YOUR_API_KEY